Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Viza

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
The New England Journal of Medicine|June 7, 1979
Transfer factor for the treatment of chronic active hepatitisG Pizza, D Viza, A Roda, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1996
In vitro studies during long-term oral administration of specific transfer factorG Pizza, C De Vinci, V Fornarola, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1996
Efficacy of transfer factor in treating patients with recurrent ocular herpes infectionsR Meduri, E Campos, L Scorolli, et al.
Journal of Experimental Pathology|January 1, 1987
Interleukin-2 treatment of lung metastases of a mammary adenocarcinoma. A case reportA Lefesvre, D Viza, M Patrasco, et al.
Journal of Virological Methods|September 1, 1988
Soluble extracts from a lymphoblastoid cell line modulate simian immunodeficiency syndrome (SAIDS) evolutionD Viza, J M Vich, A Minarro, et al.
Presse Medicale (Paris, France : 1983)|March 3, 1984
[Treatment of herpes infections with transfer factor]F Rosenfeld, D Viza, J Phillips, et al.
La Presse Medicale|November 28, 1970
[Determination, isolation and partial purification of leukemic antigens in humans]D Viza, D A Davies, R Todd, et al.
Folia Biologica|June 11, 2013
Transfer factor: an overlooked potential for the prevention and treatment of infectious diseasesD Viza, H H Fudenberg, A Palareti, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1985
Transfer factor for the treatment of HBsAg-positive chronic active hepatitisE Roda, D Viza, G Pizza, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1996
Orally administered HSV-specific transfer factor (TF) prevents genital or labial herpes relapsesG Pizza, D Viza, C De Vinci, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|June 7, 1979
Transfer factor for the treatment of chronic active hepatitisG Pizza, D Viza, A Roda, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1996
In vitro studies during long-term oral administration of specific transfer factorG Pizza, C De Vinci, V Fornarola, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1996
Efficacy of transfer factor in treating patients with recurrent ocular herpes infectionsR Meduri, E Campos, L Scorolli, et al.
Journal of Experimental Pathology|January 1, 1987
Interleukin-2 treatment of lung metastases of a mammary adenocarcinoma. A case reportA Lefesvre, D Viza, M Patrasco, et al.
Journal of Virological Methods|September 1, 1988
Soluble extracts from a lymphoblastoid cell line modulate simian immunodeficiency syndrome (SAIDS) evolutionD Viza, J M Vich, A Minarro, et al.
Presse Medicale (Paris, France : 1983)|March 3, 1984
[Treatment of herpes infections with transfer factor]F Rosenfeld, D Viza, J Phillips, et al.
La Presse Medicale|November 28, 1970
[Determination, isolation and partial purification of leukemic antigens in humans]D Viza, D A Davies, R Todd, et al.
Folia Biologica|June 11, 2013
Transfer factor: an overlooked potential for the prevention and treatment of infectious diseasesD Viza, H H Fudenberg, A Palareti, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1985
Transfer factor for the treatment of HBsAg-positive chronic active hepatitisE Roda, D Viza, G Pizza, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1996
Orally administered HSV-specific transfer factor (TF) prevents genital or labial herpes relapsesG Pizza, D Viza, C De Vinci, et al.
Pageof 6